Morning Market Losers
April 28, 2014 at 09:51 AM EDT
Athersys (NASDAQ: ATHX) shares tumbled 55.99% to $1.20 on failed trial results for ulcerative colitis. OncoGenex Pharmaceuticals ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.